User profiles for S. Morteza Seyed Jafari

Morteza Seyed Jafari

Department of Dermatology, Bern University Hospital, Switzerland
Verified email at insel.ch
Cited by 2072

Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator …

…, L Borradori, S Radonjic-Hoesli, SMS Jafari… - The Lancet …, 2021 - thelancet.com
Background B-cell-depleting therapies increase the risk of morbidity and mortality due to
COVID-19. Evidence-based SARS-CoV-2 vaccination strategies for patients on B-cell-depleting …

[HTML][HTML] Tumor-infiltrating lymphocytes and their prognostic value in cutaneous melanoma

F Maibach, H Sadozai, SM Seyed Jafari… - Frontiers in …, 2020 - frontiersin.org
Recent breakthroughs in tumor immunotherapy such as immune checkpoint blockade (ICB)
antibodies, have demonstrated the capacity of the immune system to fight cancer in a …

Salivary gland macrophages and tissue-resident CD8+ T cells cooperate for homeostatic organ surveillance

…, A Raimondi, KA Keyser, SM Seyed Jafari… - Science …, 2020 - science.org
It is well established that tissue macrophages and tissue-resident memory CD8 + T cells (T
RM ) play important roles for pathogen sensing and rapid protection of barrier tissues. In …

Human “TH9” cells are a subpopulation of PPAR-γ+ TH2 cells

…, E Kipfer, C Adam, C Simillion, SM Seyed Jafari… - Science …, 2019 - science.org
Although T H 1, T H 2, and T H 17 cells are well-defined T H cell lineages in humans, it
remains debated whether IL-9–producing T H cells represent a bona fide “T H 9” lineage. Our …

[HTML][HTML] Hidradenitis suppurativa: current understanding of pathogenic mechanisms and suggestion for treatment algorithm

SM Seyed Jafari, RE Hunger, C Schlapbach - Frontiers in medicine, 2020 - frontiersin.org
Hidradenitis suppurativa is one of the most distressing dermatological conditions and has a
significant negative impact on patients' quality of life. However, the exact pathogenic …

[HTML][HTML] Case report: combination of omalizumab and dupilumab for recalcitrant bullous pemphigoid

SM Seyed Jafari, L Feldmeyer, S Bossart… - Frontiers in …, 2021 - frontiersin.org
Bullous pemphigoid (BP) is a blistering autoimmune skin disease. Omalizumab, a monoclonal
antibody directed to IgE, showed a beneficial effect in treatment of recalcitrant BP in case …

Association of hidradenitis suppurativa with T helper 1/T helper 17 phenotypes: a semantic map analysis

R Thomi, S Cazzaniga, SMS Jafari… - JAMA …, 2018 - jamanetwork.com
Importance In spite of progress in understanding the mechanisms underlying hidradenitis
suppurativa (HS) as an inflammatory skin disease, there is still a demand for an overview on …

Apremilast in the treatment of moderate to severe hidradenitis suppurativa: a case series of 9 patients

P Weber, SMS Jafari, N Yawalkar… - Journal of the American …, 2017 - jaad.org
To the Editor: Despite the many therapeutic approaches available for hidradenitis suppurativa,
there is still a need for effective medications to treat moderate and severe forms of the …

Canakinumab for severe hidradenitis suppurativa: preliminary experience in 2 cases

C Houriet, SMS Jafari, R Thomi, C Schlapbach… - JAMA …, 2017 - jamanetwork.com
Discussion Promising effects of canakinumab, have been shown in the management of
cryopyrin-associated periodic syndrome, Muckle-Wells syndrome, familial cold auto-…

Skin hyperpigmentation after sclerotherapy with polidocanol: A systematic review

…, AA Ramelet, H Uthoff, SM Seyed Jafari… - Journal of the …, 2023 - Wiley Online Library
Skin hyperpigmentation after sclerotherapy with polidocanol‐containing sclerosants is a
common local side effect. Sclerotherapists should be familiar with factors that trigger …